Literature DB >> 1400626

Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.

K H Moberg1, W A Tyndall, D J Hall.   

Abstract

Here we analyzed the effect of the suppressor proto-oncogene p53 on transcription from the P2 promoter of the murine c-myc gene. c-myc promoter constructs were coupled to the chloramphenicol acetyl-transferase (CAT) gene and were transiently transfected into a human glial cell along with plasmids overexpressing wild-type or mutant p53. It was found that significant repression of c-myc transcription took place following cotransfection with wild-type but not mutant p53. However wild-type p53 did not suppress transcription from the SV40 early promoter or from the MHC promoter. Promoter-CAT constructs containing only the ME1a2 or E2F elements, from the P2 promoter, were repressed by p53, indicating that p53 may exert its effect at these two sites within the P2 promoter. Finally, when the SV40 T antigen and wild-type p53 were expressed together in glial cells the repressive effect of p53 was abolished.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400626     DOI: 10.1002/jcb.240490213

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.

Authors:  G M Kasof; L Goyal; E White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

2.  Functional analysis of p53 binding under differential stresses.

Authors:  Adam J Krieg; Ester M Hammond; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

3.  p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53.

Authors:  A Ori; A Zauberman; G Doitsh; N Paran; M Oren; Y Shaul
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

4.  TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression.

Authors:  Achim Weber; Juhong Liu; Irene Collins; David Levens
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  Positive regulation of c-Myc by cohesin is direct, and evolutionarily conserved.

Authors:  Jenny M Rhodes; Fiona K Bentley; Cristin G Print; Dale Dorsett; Ziva Misulovin; Emma J Dickinson; Kathryn E Crosier; Philip S Crosier; Julia A Horsfield
Journal:  Dev Biol       Date:  2010-05-27       Impact factor: 3.582

6.  Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.

Authors:  Yuan Yao; Marcia Bellon; Shary N Shelton; Christophe Nicot
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

7.  Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines.

Authors:  M O Grimm; B Jürgens; W A Schulz; K Decken; D Makri; B J Schmitz-Dräger
Journal:  Urol Res       Date:  1995

Review 8.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

9.  Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells.

Authors:  M Wu; R E Bellas; J Shen; G E Sonenshein
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

10.  Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1.

Authors:  D J O'Connor; E W Lam; S Griffin; S Zhong; L C Leighton; S A Burbidge; X Lu
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.